Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati - Gilde Healthcare

Gilde Healthcare strengthens Investor Relations and Fundraising team with Besmire Ahmati

9 juni 2023
Utrecht (The Netherlands)

Gilde Healthcare, a leading transatlantic investment firm specialized in the healthcare sector, is pleased to announce the addition of Besmire Ahmati to its team as Associate Investor Relations and Fundraising.

In this new role, Besmire will focus on supporting Gilde Healthcare’s investor relations activities and contribute to the firm’s capital raising and communications efforts. With over 5 years of experience in financial services and more recently as an LP investor, Besmire brings valuable expertise to Gilde Healthcare.

“We are pleased to welcome Besmire to our Investor Relations and Fundraising team,” said Pieter van der Meer, Managing Partner of Gilde Healthcare. “Her experience with institutional investors such as PGGM and FMO, strong industry relationships, and entrepreneurial mindset will help in building out our fundraising strategy and investor relationships.”

Prior to joining Gilde Healthcare, Besmire was part of the PGGM Private Equity team as a Junior Investment Manager investing in a global portfolio of private equity funds and co-investments. Prior to that, Besmire worked as a portfolio analyst in distressed assets transactions in private markets for FMO – the Dutch Entrepreneurial Development Bank. She began her career at Van Lanschot Kempen as an investment graduate.

“I am honored to be a part of Gilde Healthcare’s exceptional team and contribute to the firm’s continued success. I look forward to collaborating with our existing and prospective investors, delivering exceptional service, and fostering long-term partnerships with our stakeholders.” said Ahmati.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.5 billion across two fund strategies: Venture&Growth and Private Equity. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. For more information, visit the company’s website at www.gildehealthcare.com.

Gilde Healthcare company Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8...
28 april 2025

Gilde Healthcare company Tagworks Pharmaceuticals Announces FDA Clearance of IND Application and Initiation of Phase 1 Clinical Trial for TGW101

TGW101 is a next-generation, first-in-class ADC targeting TAG-72 with an MMAE payload, developed based on Tagworks proprietary Click-to-Release linker chemistry; TGW101 is the first bioorthogonal, in vivo click chemistry-activated ADC, which enables superior control of...
22 april 2025

Gilde Healthcare company SynOx Therapeutics announces Board Chair transition to align with advancing Regulatory and Commercialization Strategy

SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the execution of a planned and orderly transition of its board chair position. Philip Astley-Sparke...
1 april 2025